Evidence Review
A 2017 systematic review and meta-analysis by Batacan et al. synthesized 65 HIIT studies and found significant improvements in VO2max (SMD = 1.12), resting heart rate, systolic blood pressure, and fasting blood glucose compared to non-exercise controls [1]. Effect sizes were strongest for VO2max, indicating HIIT is highly effective at improving cardiorespiratory fitness regardless of baseline level.
The insulin and glucose data are particularly strong. Jelleyman et al. pooled 50 studies and found that HIIT significantly reduced HOMA-IR compared to both control (SMD = -0.49, 95% CI -0.87 to -0.12, p=0.009) and continuous training (SMD = -0.35, p=0.036) [2]. In populations with or at risk for type 2 diabetes, fasting glucose fell by 0.92 mmol/L, HbA1c dropped 0.19%, and body weight decreased 1.3 kg on average versus control. These are clinically meaningful reductions achievable without medication.
De Strijcker et al. ran a direct RCT comparison of HIIT versus continuous aerobic training in 16 overweight/obese males over 10 weeks [4]. At matched weekly training volume, HIIT produced significantly greater improvements in insulin sensitivity (measured by OGTT composite score and AUC insulin), skeletal muscle mitochondrial content (citrate synthase activity in biopsies), and VO2max. The resting respiratory exchange ratio also fell more in the HIIT group, indicating a shift toward fat oxidation at rest — a marker of improved metabolic flexibility.
HIIT in older adults:
Wu et al. conducted a meta-analysis of RCTs in older adults and found HIIT significantly improved VO2peak versus moderate-intensity continuous training [3]. Favorable adaptations included better cardiac contractile function, increased mitochondrial citrate synthase activity, reduced blood triglycerides, and lower fasting glucose. Protocols producing the best VO2peak outcomes used training periods over 12 weeks, two sessions per week, 40-minute sessions, and rest intervals under 90 seconds between work bouts [3]. This matters because cardiorespiratory fitness declines roughly 10% per decade after age 30, and HIIT appears to substantially offset this trajectory.
Comparative effectiveness versus moderate-intensity continuous training (MICT):
HIIT consistently matches or outperforms MICT for VO2max gains while requiring 40-50% less time commitment [1]. For insulin resistance, HIIT shows advantages over MICT even at lower training volumes [2]. HbA1c outcomes are similar between modalities. Evidence for visceral fat reduction slightly favors HIIT. These data suggest HIIT is not simply an equivalent substitute for longer cardio — it appears to be a superior stimulus per unit of time for several key metabolic and cardiovascular outcomes.
Limitations:
Most HIIT trials are short (8-12 weeks), conducted in supervised settings, and recruit sedentary or overweight participants at baseline. Long-term real-world adherence is less well characterized. The optimal protocol remains undefined and likely varies by goal and individual. Some studies conflate HIIT with sprint interval training (SIT), which uses even shorter and more intense bursts, complicating cross-study comparisons. Unsupervised running-based HIIT carries a higher injury risk than the supervised settings of most trials, particularly for those with joint issues or low baseline fitness.